Heart failure in Fabry disease revisited: application of current heart failure guidelines and recommendations

by Daniel Rob, Josef Marek, Gabriela Dostalova, Ales Linhart
Published 2022-12-01

Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease.

by Daniel Rob, Josef Marek, Gabriela Dostálová, Lubor Goláň, Aleš Linhart
Published 2016-01-01

Correction: Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease.

by Daniel Rob, Josef Marek, Gabriela Dostálová, Lubor Goláň, Aleš Linhart
Published 2017-01-01

Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up

by Gabriela Dostálová, Zuzana Hlubocká, Kristýna Bayerová, Jan Bělohlávek, Aleš Linhart, Debora Karetová
Published 2017-11-01

Serum Bilirubin and Markers of Oxidative Stress and Inflammation in a Healthy Population and in Patients with Various Forms of Atherosclerosis

by Libor Vítek, Alena Jirásková, Ivana Malíková, Gabriela Dostálová, Lenka Eremiášová, Vilém Danzig, Aleš Linhart, Martin Haluzík
Published 2022-10-01

Anderson–Fabry Disease Homozygosity: Rare Case of Late-Onset Variant

by Gabriela Dostalova, Jaroslav Januska, Michaela Veselá, Petra Reková, Anna Taborska, Martin Pleva, David Zemanek, Aleš Linhart
Published 2024-04-01

Assessment of Asymptomatic Severe Aortic Regurgitation by Doppler-Derived Echo Indices: Comparison with Magnetic Resonance Quantification

by Zuzana Hlubocká, Radka Kočková, Hana Línková, Alena Pravečková, Jaroslav Hlubocký, Gabriela Dostálová, Martin Bláha, Martin Pěnička, Aleš Linhart
Published 2021-12-01

Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study

by Aleš Linhart, Gabriela Dostálová, Kathy Nicholls, Michael L. West, Camilla Tøndel, Ana Jovanovic, Pilar Giraldo, Bojan Vujkovac, Tarekegn Geberhiwot, Einat Brill-Almon, Sari Alon, Raul Chertkoff, Rossana Rocco, Derralynn Hughes
Published 2023-10-01

Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic

by David Zemánek, Jaroslav Januška, Tomáš Honěk, Karol Čurila, Miloš Kubánek, Štěpánka Šindelářová, Lucie Zahálková, Petr Klofáč, Eliška Laštůvková, Eva Lichnerová, Renata Aiglová, Jan Lhotský, Jiří Vondrák, Gabriela Dostálová, Miloš Táborský, David Kasper, Aleš Linhart
Published 2022-12-01

Detailed Phenotype of GLA Variants Identified by the Nationwide Neurological Screening of Stroke Patients in the Czech Republic

by Petra Reková, Gabriela Dostálová, David Kemlink, Jaroslava Paulasová Schwabová, Zora Dubská, Manuela Vaneckova, Martin Mašek, Ondřej Kodet, Helena Poupětová, Stella Mazurová, Aneta Rajdova, Eva Vlckova, Alena Táboříková, Štěpánka Fafejtová, Miroslava Nevsimalova, Aleš Linhart, Aleš Tomek
Published 2021-08-01

Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial.

by Frits A Wijburg, Bernard Bénichou, Daniel G Bichet, Lorne A Clarke, Gabriela Dostalova, Alejandro Fainboim, Andreas Fellgiebel, Cassiano Forcelini, Kristina An Haack, Robert J Hopkin, Michael Mauer, Behzad Najafian, C Ronald Scott, Suma P Shankar, Beth L Thurberg, Camilla Tøndel, Anna Tylki-Szymańska, Uma Ramaswami
Published 2015-01-01

Nationwide screening for Fabry disease in unselected stroke patients.

by Aleš Tomek, Reková Petra, Jaroslava Paulasová Schwabová, Anna Olšerová, Miroslav Škorňa, Miroslava Nevšímalová, Libor Šimůnek, Roman Herzig, Štěpánka Fafejtová, Petr Mikulenka, Alena Táboříková, Jiří Neumann, Richard Brzezny, Helena Sobolová, Jan Bartoník, Daniel Václavík, Marta Vachová, Karel Bechyně, Hana Havlíková, Tomáš Prax, Daniel Šaňák, Irena Černíková, Iva Ondečková, Petr Procházka, Jan Rajner, Miroslav Škoda, Jan Novák, Ondřej Škoda, Michal Bar, Robert Mikulík, Gabriela Dostálová, Aleš Linhart, National Stroke Research Network, part of Czech Clinical Research Infrastructure Network (CZECRIN) and Czech Neurological Society, Cerebrovascular Section
Published 2021-01-01